<font color="blue">Salbutamol_3</font> or <font color="blue">mist_1</font> in acute bronchiolitis . 
<br>
<br> BACKGROUND The role of <font color="blue">bronchodilators_1</font> in the treatment of bronchiolitis remains controversial . 
<br> METHODS A double - blind , <font color="blue">placebo_1</font> controlled trial was performed to evaluate the clinical response to nebulized <font color="blue">salbutamol_2</font> <font color="blue">._2</font> One hundred and fifty - six infants aged between 7 weeks and 24 months who had had an episode of wheezing and other signs and symptoms of bronchiolitis were randomized to three groups as follows : ( i ) <font color="blue">nebulized_2</font> <font color="blue">salbutamol_5</font> <font color="blue">was_1</font> <font color="blue">administered_1</font> <font color="blue">to_1</font> <font color="blue">52_1</font> <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">group_1</font> <font color="blue">I_1</font> <font color="blue">at_1</font> <font color="blue">a_1</font> <font color="blue">dose_1</font> <font color="blue">of_1</font> <font color="blue">0.15_1</font> <font color="blue">mg_1</font> <font color="blue">/_1</font> <font color="blue">kg_1</font> <font color="blue">in_1</font> <font color="blue">2_1</font> <font color="blue">mL_1</font> <font color="blue">saline_2</font> <font color="blue">;_2</font> <font color="blue">(_1</font> <font color="blue">ii_1</font> <font color="blue">)_1</font> <font color="blue">saline_5</font> <font color="blue">was_2</font> <font color="blue">nebulized_2</font> <font color="blue">to_1</font> <font color="blue">52_1</font> <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">group_1</font> <font color="blue">II_1</font> <font color="blue">and_1</font> <font color="blue">(_1</font> <font color="blue">iii_1</font> <font color="blue">)_1</font> <font color="blue">in_1</font> <font color="blue">group_1</font> <font color="blue">III_1</font> <font color="blue">52_1</font> <font color="blue">patients_1</font> <font color="blue">received_1</font> <font color="blue">mist_3</font> <font color="blue">in_1</font> <font color="blue">a_1</font> <font color="blue">tent_1</font> <font color="blue">._1</font> All three groups were <font color="blue">administered_1</font> <font color="blue">oxygen_3</font> <font color="blue">during_1</font> <font color="blue">the_1</font> <font color="blue">procedures_1</font> <font color="blue">._1</font> Treatment was repeated with the same agent after 30 min if the respiratory score was 5 or more . Respiratory rate , heart rate , oxygen saturation and presence of cyanosis , wheezing , retractions were recorded before and after each treatment . 
<br> RESULTS The decrease in the respiratory score was 5.2 + /- 1.8 , 0.82 + /- 2.4 and 1.7 + /- 1.3 in <font color="blue">group_1</font> <font color="blue">I_1</font> <font color="blue">,_1</font> <font color="blue">II_1</font> <font color="blue">and_1</font> <font color="blue">III_1</font> <font color="blue">,_1</font> respectively . The decrease in <font color="blue">group_1</font> <font color="blue">I_1</font> was significantly higher than in the <font color="blue">other_1</font> <font color="blue">groups_1</font> <font color="blue">._1</font> Heart rate was similar between groups . Oxygen saturation decreased in <font color="blue">group_1</font> <font color="blue">I_1</font> without reaching statistical significance . 
<br> CONCLUSIONS <font color="blue">Salbutamol_2</font> was shown to be effective and safe in the treatment of acute bronchiolitis .